XML 41 R31.htm IDEA: XBRL DOCUMENT v3.19.1
12. STOCKHOLDERS' EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Feb. 28, 2019
Equity [Abstract]  
Changes in the components of AOCI

    Changes in the components of AOCI, net of tax, were as follows (in thousands):

 

    Cumulative
Translation
Adjustments
    Unrealized Loss
on Investments,
Net
    Total  
                   
Balance at May 31, 2018   $ 2,292     $ --     $ 2,292  
Other comprehensive (loss) income before reclassifications     (40 )     --       (40 )
Amounts reclassified out of AOCI     --       --       --  
Other comprehensive (loss) income, net of tax     (40 )     --       (40 )
Balance at February 28, 2019   $ 2,252     $ --     $ 2,252  

 

Compensation costs related to the Company's stock-based compensation

    The following table summarizes the stock-based compensation expense for the three and nine months ended February 28, 2019 and 2018 (in thousands):

 

    Three Months Ended     Nine Months Ended  
    February 28,      February 28,  
    2019     2018     2019     2018  
Stock-based compensation in the form of employee stock options, RSUs and
ESPP purchase rights, included in:
                       
Cost of sales   $ 24     $ 28     $ 83     $ 107  
Selling, general and administrative     137       162       421       530  
Research and development     64       52       201       185  
Total stock-based compensation   $ 225     $ 242     $ 705     $ 822  

 

Fair value assumptions for option valuation model

    Fair Value. The fair value of the Company’s stock options granted to employees for the three and nine months ended February 28, 2019 and 2018 were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:

 

    Three Months Ended     Nine Months Ended  
    February 28,     February 28,  
    2019     2018     2019     2018  
                         
Expected term (in years)     5       4       5       4  
Volatility     0.69       0.73       0.72       0.77  
Risk-free interest rate     2.77 %     2.31 %     2.83 %     1.81 %
Weighted average grant date fair value   $ 1.01     $ 1.53     $ 1.34     $ 2.17  

 

    The fair values of the ESPP purchase rights granted for the nine months ended February 28, 2019 were estimated using the following weighted-average assumptions:

 

    Nine Months
Ended
 
    February 28, 2019  
       
Expected term (in years)     0.5-2.0  
Volatility     0.48-0.64  
Expected dividend   $ 0.00  
Risk-free interest rates     2.40%-2.82%  
Estimated forfeiture rate     0%  
Weighted average grant date fair value   $ 1.15  

 

Stock option and RSU transactions

    The following tables summarize the Company’s stock option and RSU transactions during three and nine months ended February 28, 2019 (in thousands):

 

    Available  
    Shares  
Balance, May 31, 2018     1,812  
         
  Options granted     (441 )
  Shares cancelled     13  
  Shares expired     (11 )
         
Balance, August 31, 2018     1,373  
         
  Options granted     (248 )
  Shares cancelled     45  
  Shares expired     (33 )
         
Balance, November 30, 2018     1,137  
         
  Options granted     (100 )
  Shares cancelled     51  
  Shares expired     (1 )
         
Balance, February 28, 2019     1,087  

 

Stock option transactions

    The following table summarizes the stock option transactions during the three and nine months ended February 28, 2019 (in thousands, except per share data):

 

    Outstanding Options  
          Weighted        
    Number     Average     Aggregate  
    of     Exercise     Intrinsic  
    Shares     Price     Value  
Balances, May 31, 2018     2,859     $ 2.04     $ 1,987  
                         
Options granted     441     $ 2.40          
Options cancelled     (13 )   $ 1.64          
Options exercised     (98 )   $ 1.12          
                         
Balances, August 31, 2018     3,189     $ 2.12     $ 1,757  
                         
Options granted     248     $ 2.03          
Options cancelled     (45 )   $ 2.70          
Options exercised     (19 )   $ 1.09          
                         
Balances, November 30, 2018     3,373     $ 2.11     $ 679  
                         
Options granted     100     $ 1.71          
Options cancelled     (51 )   $ 1.72          
Options exercised     (202 )   $ 0.61          
                         
Balances, February 28, 2019     3,220     $ 2.20     $ 120  
                         
Options fully vested and expected to vest at February 28, 2019     3,184     $ 2.20     $ 120  

 

Options outstanding

    The options outstanding and exercisable at February 28, 2019 were in the following exercise price ranges (in thousands, except per share data):

 

        Options Outstanding     Options Exercisable  
        at February 28, 2019     at February 28, 2019  
 

Range of
Exercise

Prices

    Number
Outstanding
Shares
    Weighted
Average
Remaining
Contractual Life
(Years)
    Weighted
Average Exercise
Price
    Number
Exercisable
Shares
    Weighted
Average
Remaining
Contractual Life
(Years)
    Weighted
Average Exercise
Price
   

Aggregate
Intrinsic
Value

 
  $ 0.80-$0.97       47       0.77     $ 0.85       47       0.77     $ 0.85          
  $ 1.09-$1.28       498       0.97     $ 1.28       498       0.97     $ 1.28          
  $ 1.68-$2.06       763       4.76     $ 1.83       386       3.54     $ 1.79          
  $ 2.10-$2.81       1,651       3.88     $ 2.43       1,199       2.98     $ 2.44          
  $ 3.46-$3.93       261       5.41     $ 3.86       128       5.45     $ 3.78          
  $ 0.80-$3.93       3,220       3.72     $ 2.20       2,258       2.73     $ 2.11     $ 120